Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.
In terms of geographical regions, the Americas will account for almost 50% of the total market shares and will also be the major revenue contributor to the gastrointestinal therapeutics market throughout the forecast period. The rising acceptance of biologics and the introduction of healthcare reforms by various countries in the region will augment the market's growth prospects in the next few years.
In 2018, the global Gastrointestinal Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Gastrointestinal Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastrointestinal Therapeutics development in United States, Europe and China.
The key players covered in this study
- AbbVie
- Allergan
- Johnson & Johnson
- Takeda
- Novartis
- Pfizer
- Merck
- F. Hoffmann-La Roche
- Eli Lilly
- AstraZeneca
- Procter & Gamble
- Tillotts Pharma
- Shire Pharmaceuticals
- GlaxoSmithKline
- Amgen
Market segment by Type, the product can be split into
Market segment by Application, split into
- IBD
- Irritable Bowel Syndrome (IBS)
Market segment by Regions/Countries, this report covers
- United States
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
The study objectives of this report are:
- To analyze global Gastrointestinal Therapeutics status, future forecast, growth opportunity, key market and key players.
- To present the Gastrointestinal Therapeutics development in United States, Europe and China.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Gastrointestinal Therapeutics are as follows:
- History Year: 2014-2018
- Base Year: 2018
- Estimated Year: 2019
- Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Oral
- 1.4.3 Parenteral
- 1.5 Market by Application
- 1.5.1 Global Gastrointestinal Therapeutics Market Share by Application (2014-2025)
- 1.5.2 IBD
- 1.5.3 Irritable Bowel Syndrome (IBS)
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Gastrointestinal Therapeutics Market Size
- 2.2 Gastrointestinal Therapeutics Growth Trends by Regions
- 2.2.1 Gastrointestinal Therapeutics Market Size by Regions (2014-2025)
- 2.2.2 Gastrointestinal Therapeutics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Gastrointestinal Therapeutics Market Size by Manufacturers
- 3.1.1 Global Gastrointestinal Therapeutics Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Gastrointestinal Therapeutics Key Players Head office and Area Served
- 3.3 Key Players Gastrointestinal Therapeutics Product/Solution/Service
- 3.4 Date of Enter into Gastrointestinal Therapeutics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Gastrointestinal Therapeutics Market Size by Type (2014-2019)
- 4.2 Global Gastrointestinal Therapeutics Market Size by Application (2014-2019)
5 United States
- 5.1 United States Gastrointestinal Therapeutics Market Size (2014-2019)
- 5.2 Gastrointestinal Therapeutics Key Players in United States
- 5.3 United States Gastrointestinal Therapeutics Market Size by Type
- 5.4 United States Gastrointestinal Therapeutics Market Size by Application
6 Europe
- 6.1 Europe Gastrointestinal Therapeutics Market Size (2014-2019)
- 6.2 Gastrointestinal Therapeutics Key Players in Europe
- 6.3 Europe Gastrointestinal Therapeutics Market Size by Type
- 6.4 Europe Gastrointestinal Therapeutics Market Size by Application
7 China
- 7.1 China Gastrointestinal Therapeutics Market Size (2014-2019)
- 7.2 Gastrointestinal Therapeutics Key Players in China
- 7.3 China Gastrointestinal Therapeutics Market Size by Type
- 7.4 China Gastrointestinal Therapeutics Market Size by Application
8 Japan
- 8.1 Japan Gastrointestinal Therapeutics Market Size (2014-2019)
- 8.2 Gastrointestinal Therapeutics Key Players in Japan
- 8.3 Japan Gastrointestinal Therapeutics Market Size by Type
- 8.4 Japan Gastrointestinal Therapeutics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Gastrointestinal Therapeutics Market Size (2014-2019)
- 9.2 Gastrointestinal Therapeutics Key Players in Southeast Asia
- 9.3 Southeast Asia Gastrointestinal Therapeutics Market Size by Type
- 9.4 Southeast Asia Gastrointestinal Therapeutics Market Size by Application
10 India
- 10.1 India Gastrointestinal Therapeutics Market Size (2014-2019)
- 10.2 Gastrointestinal Therapeutics Key Players in India
- 10.3 India Gastrointestinal Therapeutics Market Size by Type
- 10.4 India Gastrointestinal Therapeutics Market Size by Application
11 Central & South America
- 11.1 Central & South America Gastrointestinal Therapeutics Market Size (2014-2019)
- 11.2 Gastrointestinal Therapeutics Key Players in Central & South America
- 11.3 Central & South America Gastrointestinal Therapeutics Market Size by Type
- 11.4 Central & South America Gastrointestinal Therapeutics Market Size by Application
12 International Players Profiles
- 12.1 AbbVie
- 12.1.1 AbbVie Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Gastrointestinal Therapeutics Introduction
- 12.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2014-2019)
- 12.1.5 AbbVie Recent Development
- 12.2 Allergan
- 12.2.1 Allergan Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Gastrointestinal Therapeutics Introduction
- 12.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2014-2019)
- 12.2.5 Allergan Recent Development
- 12.3 Johnson & Johnson
- 12.3.1 Johnson & Johnson Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Gastrointestinal Therapeutics Introduction
- 12.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2014-2019)
- 12.3.5 Johnson & Johnson Recent Development
- 12.4 Takeda
- 12.4.1 Takeda Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Gastrointestinal Therapeutics Introduction
- 12.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2014-2019)
- 12.4.5 Takeda Recent Development
- 12.5 Novartis
- 12.5.1 Novartis Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Gastrointestinal Therapeutics Introduction
- 12.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2014-2019)
- 12.5.5 Novartis Recent Development
- 12.6 Pfizer
- 12.6.1 Pfizer Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Gastrointestinal Therapeutics Introduction
- 12.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2014-2019)
- 12.6.5 Pfizer Recent Development
- 12.7 Merck
- 12.7.1 Merck Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Gastrointestinal Therapeutics Introduction
- 12.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2014-2019)
- 12.7.5 Merck Recent Development
- 12.8 F. Hoffmann-La Roche
- 12.8.1 F. Hoffmann-La Roche Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Gastrointestinal Therapeutics Introduction
- 12.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2014-2019)
- 12.8.5 F. Hoffmann-La Roche Recent Development
- 12.9 Eli Lilly
- 12.9.1 Eli Lilly Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Gastrointestinal Therapeutics Introduction
- 12.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2014-2019)
- 12.9.5 Eli Lilly Recent Development
- 12.10 AstraZeneca
- 12.10.1 AstraZeneca Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Gastrointestinal Therapeutics Introduction
- 12.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2014-2019)
- 12.10.5 AstraZeneca Recent Development
- 12.11 Procter & Gamble
- 12.12 Tillotts Pharma
- 12.13 Shire Pharmaceuticals
- 12.14 GlaxoSmithKline
- 12.15 Amgen
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.2 Disclaimer
- 15.3 Author Details
